Mehmet Şencan

793 total citations
41 papers, 585 citations indexed

About

Mehmet Şencan is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Mehmet Şencan has authored 41 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Genetics and 7 papers in Immunology. Recurrent topics in Mehmet Şencan's work include Multiple Myeloma Research and Treatments (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Mehmet Şencan is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Mehmet Şencan collaborates with scholars based in Türkiye, United States and Iran. Mehmet Şencan's co-authors include Serdal Korkmaz, Hatice Sebila Dökmetaş, A. Uslu, Soner Şenel, İlyas Dökmetaş, Ece Kaptanoğlu, Hasan Elden, Vedat Nacitarhan, Enver Sancakdar and Köksal Deveci and has published in prestigious journals such as BioMed Research International, BMC Infectious Diseases and Journal of Infection.

In The Last Decade

Mehmet Şencan

39 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mehmet Şencan Türkiye 12 149 103 77 75 71 41 585
Maria Lopez-Bresnahan United States 13 42 0.3× 95 0.9× 56 0.7× 93 1.2× 121 1.7× 15 692
Derrick J. Stobaugh United States 14 33 0.2× 84 0.8× 35 0.5× 62 0.8× 55 0.8× 30 619
Derrick Robertson United States 11 165 1.1× 38 0.4× 65 0.8× 77 1.0× 137 1.9× 46 804
Feng Qiu China 12 388 2.6× 29 0.3× 114 1.5× 78 1.0× 47 0.7× 34 785
Enver Sancakdar Türkiye 12 61 0.4× 60 0.6× 88 1.1× 26 0.3× 55 0.8× 32 378
Pablo A. López Argentina 12 80 0.5× 57 0.6× 31 0.4× 73 1.0× 39 0.5× 53 449
İlknur Erol Türkiye 18 89 0.6× 31 0.3× 141 1.8× 91 1.2× 32 0.5× 78 896
Yangzhong Zhou China 13 108 0.7× 26 0.3× 141 1.8× 38 0.5× 51 0.7× 46 568
Gülşen Köse Türkiye 16 129 0.9× 18 0.2× 139 1.8× 54 0.7× 24 0.3× 55 790
Joseph Kamtchum‐Tatuene Canada 17 76 0.5× 73 0.7× 116 1.5× 19 0.3× 21 0.3× 51 909

Countries citing papers authored by Mehmet Şencan

Since Specialization
Citations

This map shows the geographic impact of Mehmet Şencan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehmet Şencan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehmet Şencan more than expected).

Fields of papers citing papers by Mehmet Şencan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehmet Şencan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehmet Şencan. The network helps show where Mehmet Şencan may publish in the future.

Co-authorship network of co-authors of Mehmet Şencan

This figure shows the co-authorship network connecting the top 25 collaborators of Mehmet Şencan. A scholar is included among the top collaborators of Mehmet Şencan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehmet Şencan. Mehmet Şencan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doğan, Halef Okan, et al.. (2025). Determination of Serum Interleukin-36 Alpha, Beta, Gamma, and Interleukin-17 Levels in Patients with Non-Hodgkin Lymphoma. Düzce Tıp Fakültesi Dergisi. 27(1). 23–28. 1 indexed citations
2.
Şencan, Mehmet, et al.. (2021). In vitro comparison of the cytotoxic effects of lenalidomide alone and in combination with verapamil on myeloma cell line. The Egyptian Journal of Haematology. 46(3). 185–191. 1 indexed citations
3.
Aydoğdu, İsmet, Mehmet Şencan, Ali Kaya, et al.. (2017). Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience. Hematological Oncology. 36(1). 116–120. 4 indexed citations
4.
Korkmaz, Serdal, İlhami Berber, Muzaffer Keklık, et al.. (2017). Clinical Characteristics and Treatments Outcomes in Elderly Patients with Multiple Myeloma: A Multicenter Retrospective Study. Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi. 39(1). 389–389. 2 indexed citations
5.
6.
Korkmaz, Selçuk, et al.. (2015). The Emergence of Multiple Myeloma in a Patient with Essential Thrombocythemia: A Case Report. 1(1). 1 indexed citations
7.
Semız, Murat, Ali Uğur Uslu, Serdal Korkmaz, et al.. (2015). Assessment of subjective sleep quality in iron deficiency anaemia. African Health Sciences. 15(2). 621–621. 39 indexed citations
8.
Kaya, Şafak, Nazif Elaldı, Ayhan Kubar, et al.. (2014). Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-α, IL-6, IL-10, and IFN-γ levels in patients with Crimean-Congo hemorrhagic fever. BMC Infectious Diseases. 14(1). 416–416. 55 indexed citations
9.
Korkmaz, Serdal, et al.. (2013). Pre-treatment and post-treatment changes in platelet indices in patients with immune thrombocytopenia.. PubMed. 34(6). 591–6. 4 indexed citations
10.
Deveci, Köksal, Serdal Korkmaz, Soner Şenel, et al.. (2013). Do neutrophil gelatinase-associated lipocalin and interleukin-18 predict renal dysfunction in patients with familial Mediterranean fever and amyloidosis?. Renal Failure. 36(3). 339–344. 6 indexed citations
11.
Kılıç, Suar Çakı, et al.. (2013). Assessing anxiety levels and empathic tendency in blood and platelet donors. Transfusion and Apheresis Science. 48(3). 297–300. 2 indexed citations
12.
Korkmaz, Serdal, Muzaffer Keklık, Serdar Şıvgın, et al.. (2013). Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: A retrospective multicenter study. Transfusion and Apheresis Science. 48(3). 353–358. 21 indexed citations
13.
Korkmaz, Serdal, et al.. (2012). Unusual manifestations of acute Q fever: autoimmune hemolytic anemia and tubulointerstitial nephritis. Annals of Clinical Microbiology and Antimicrobials. 11(1). 14–14. 11 indexed citations
14.
15.
Elaldı, Nazif, et al.. (2010). Kırım-Kongo kanamalı ateşi’nin kan merkezi iş yüküne etkisi. Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi. 32(4). 292–297.
16.
17.
Şencan, Mehmet & Hatice Sebila Dökmetaş. (2005). A Case of Postpartum Hypopituitarism Accompanied by Cushing's Syndrome as a Result of an Adrenocortical Carcinoma. Endocrine Journal. 52(2). 219–222. 2 indexed citations
18.
Elden, Hasan, et al.. (2004). The prevalence of diffuse idiopathic skeletal hyperostosis in patients with diabetes mellitus. Rheumatology International. 25(7). 518–521. 63 indexed citations
19.
Ergür, Ayça Törel, et al.. (1998). Prophylaxis of the Occurrence of Hyperbilirubinemia in Relation to Maternal Oxytocin Infusion with Steroid Treatment. Gynecologic and Obstetric Investigation. 46(3). 164–168. 5 indexed citations
20.
Türkay, Cansel, et al.. (1992). Treatment of Renal Anaemia With Recombinant Human Erythropoietin. The Anatolian Journal of General Medical Research. 2(2). 123–126. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Lopez-Bresnahan Breakdown of academic impact, for papers by Derrick J. Stobaugh Breakdown of academic impact, for papers by Derrick Robertson Breakdown of academic impact, for papers by Feng Qiu Breakdown of academic impact, for papers by Enver Sancakdar Breakdown of academic impact, for papers by Pablo A. López Breakdown of academic impact, for papers by İlknur Erol Breakdown of academic impact, for papers by Yangzhong Zhou Breakdown of academic impact, for papers by Gülşen Köse Breakdown of academic impact, for papers by Joseph Kamtchum‐Tatuene
Rankless by CCL
2026